"uri","answering body","answer > is ministerial correction","answer > date of answer","answer > answer text","answer > answering member printed","answer > grouped question UIN","answer > question first answered","answer > uri","answer > answering member > label","answer > uri","answer > attachment > file name","answer > attachment > title","answering dept id","answering dept short name","answering dept sort name","date","hansard heading","house id","legislature > pref label","question text","registered interest","tabling member > label","tabling member printed","uin" "http://data.parliament.uk/resources/386886","Department of Health","false","2015-07-14","
There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.
Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register
The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:
http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf.
We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.
","Lord Prior of Brampton","HL996 ; HL997","2015-07-14T15:34:29.197Z","http://data.parliament.uk/resources/386886/answer","Biography information for Lord Prior of Brampton","http://data.parliament.uk/resources/386886/answer","NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf","2013-14 Annual Report","17","Health","Health","2015-07-01","Amyloidosis and Multiple Myeloma","2","House of Lords","To ask Her Majesty’s Government whether they will place in the Library of the House any publications resulting from the phase 3 clinical trials approved for the potential treatment of systemic amyloidosis or multiple myeloma; and what is the National Institute of Health Research’s assessment of progress in these areas.","false","Biography information for Lord Willis of Knaresborough","Lord Willis of Knaresborough","HL995" "http://data.parliament.uk/resources/753307","Department for Communities and Local Government","false","2017-09-11","
Time spent in temporary accommodation means that no family with a child ever has to be without a roof over their heads. The number of households in temporary accommodation is well below the peak over a decade ago, in 2005.
But temporary accommodation is an intermediate measure. This government changed the law to allow councils to place families in decent and affordable private rented homes. This means homeless households do not have to wait as long for settled accommodation, spending less time in temporary accommodation.
We have also replaced DWP’s Temporary Accommodation Management Fee with a Flexible Homelessness Support Grant which local authorities can use more strategically to prevent and tackle homelessness. This amounts to £402m over the two years from 2017/18.
This government is implementing the most ambitious legislative reform in decades, the Homelessness Reduction Act, which significantly reforms England’s homelessness legislation, ensuring that more people get the help they need earlier to prevent them from becoming homeless in the first place.
The Act places duties on local authorities to intervene at earlier stages to prevent homelessness in their areas. It also requires local authorities to provide new homelessness services to all those affected, not just those who are protected under existing legislation.
I will place detailed figures in the Library of the House.
","Lord Bourne of Aberystwyth","HL993 ; HL994","2017-09-11T14:53:48.983Z","http://data.parliament.uk/resources/753307/answer","Biography information for Lord Bourne of Aberystwyth","http://data.parliament.uk/resources/753307/answer",,,"7","Communities and Local Government","Communities and Local Government","2017-07-18",,"2","House of Lords","Her Majesty's Government what is their estimate of the number of children housed in temporary accommodation in each year from 2005 to 2016.","false","Biography information for Lord Kennedy of Southwark","Lord Kennedy of Southwark","HL995" "http://data.parliament.uk/resources/533031","Department for Transport","false","2016-07-12","
Safety and security are of paramount importance, these issues were considered by the Airports Commission and will be given due regard again at appropriate points in the process following any preferred scheme being announced.
","Lord Ahmad of Wimbledon",,"2016-07-12T12:33:53.467Z","http://data.parliament.uk/resources/533031/answer","Biography information for Lord Ahmad of Wimbledon","http://data.parliament.uk/resources/533031/answer",,,"27","Transport","Transport","2016-07-05","Temporary Accommodation: Children","2","House of Lords","To ask Her Majesty’s Government whether when undertaking further work on the options for airport expansion they will include a review of the current safety and security risks associated with each option for expansion.","false","Biography information for Baroness Randerson","Baroness Randerson","HL995"